Evidence map›Paper›PMID 33296851›Full record

ArticleDiagnostic microbiology and infectious disease2021

Seroprevalence of SARS-CoV-2 (COVID-19) among healthcare workers in Saudi Arabia: comparing case and control hospitals.

Haleema Ali Alserehi, Ada Mohammed Alqunaibet, Jaffar A Al-Tawfiq, Naif Khalaf Alharbi, Abeer Nizar Alshukairi, Khalid Hamdan Alanazi, Ghada Mohammed Bin Saleh, Amer Mohammed Alshehri, Abdulrahman Almasoud, Anwar M Hashem and 11 more

Open access · greenAbstract readComparative Study
In one paragraph

Article in Diagnostic microbiology and infectious disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 1 synthesis or guideline pooled it, 74 citations in OpenAlex.

  1. Seroprevalence of IgG antibodies against SARS-CoV-2 in India, March 2020 to August 2021: a systematic review and meta-analysis.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 8 institutions in 2 countries.

Haleema Ali AlserehiExecutive Department of Global Health, Epidemiology, surveillance and preparedness affairs, Executive Department of Research, Saudi Center for Disease Prevention and Control, Riyadh, Saudi Arabia. Electronic address: dr_al_serihi@hotmail.com.
Ada Mohammed AlqunaibetExecutive Department of Global Health, Epidemiology, surveillance and preparedness affairs, Executive Department of Research, Saudi Center for Disease Prevention and Control, Riyadh, Saudi Arabia.
Jaffar A Al-TawfiqInfectious Disease Unit, Specialty Internal Medicine, and Quality and Patient Safety Departement, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia; Infectious Disease Division, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA; Infectious Disease Division, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address: jaffar.tawfiq@jhah.com.
Naif Khalaf AlharbiVaccine Development Unit, Department of Infectious Disease Research, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia; King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
Abeer Nizar AlshukairiDepartment of medicine, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia.
Khalid Hamdan AlanaziInfection and Control Department, Ministry of Health, Riyadh, Saudi Arabia.
Ghada Mohammed Bin SalehInfection and Control Department, Ministry of Health, Riyadh, Saudi Arabia.
Amer Mohammed AlshehriPublic Health Lab, Saudi Center for Disease Prevention and Control, Riyadh, Saudi Arabia.
Abdulrahman AlmasoudVaccine Development Unit, Department of Infectious Disease Research, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Anwar M HashemDepartment of Medical Microbiology and Parasitology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia; Vaccines and Immunotherapy Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.
Amaal Rabie AlruwailyExecutive Department of Global Health, Epidemiology, surveillance and preparedness affairs, Executive Department of Research, Saudi Center for Disease Prevention and Control, Riyadh, Saudi Arabia.
Rehab Habeeb AlaswadExecutive Department of Global Health, Epidemiology, surveillance and preparedness affairs, Executive Department of Research, Saudi Center for Disease Prevention and Control, Riyadh, Saudi Arabia.
Hind Mohammed Al-MutlaqExecutive Department of Global Health, Epidemiology, surveillance and preparedness affairs, Executive Department of Research, Saudi Center for Disease Prevention and Control, Riyadh, Saudi Arabia.
Abdulllah Ali AlmudaiheemExecutive Department of Global Health, Epidemiology, surveillance and preparedness affairs, Executive Department of Research, Saudi Center for Disease Prevention and Control, Riyadh, Saudi Arabia.
Fatmah Mahmoud OthmanResearch department, College of Applied Medical Sciences, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
Sumyah Abdullah AldakeelPublic Health Lab, Saudi Center for Disease Prevention and Control, Riyadh, Saudi Arabia.
Mouath Rashid Abu GhararahPublic Health Lab, Saudi Center for Disease Prevention and Control, Riyadh, Saudi Arabia.
Hani Abdulaziz JokhdarPublic Health, Ministry of Health, Riyadh, Saudi Arabia.
Abdullah Rshoud AlgwizaniSaudi Cenetr for Disease Control and Prevention, Riyadh, Saudi Arabia.
Sami Saeed AlmudarraExecutive Department of Global Health, Epidemiology, surveillance and preparedness affairs, Executive Department of Research, Saudi Center for Disease Prevention and Control, Riyadh, Saudi Arabia.
Ahmed Mohammed AlbarragPublic Health Lab, Saudi Center for Disease Prevention and Control, Riyadh, Saudi Arabia; Department of Pathology, School of Medicine, King Saud University, Riyadh, Saudi Arabia.
Saudi Center for Disease Prevention and Control · SAMinistry of Health · SAKing Saud bin Abdulaziz University for Health Sciences · SAJohns Hopkins University · USKing Abdulaziz University · SAKing Abdullah International Medical Research Center · SAKing Faisal Specialist Hospital & Research Centre · SAKing Saud University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Healthcare workers (HCWs) stand at the frontline for fighting coronavirus disease 2019 (COVID-19) pandemic. This puts them at higher risk of acquiring the infection than other individuals in the community. Defining immunity status among health care workers is therefore of interest since it helps to mitigate the exposure risk. This study was conducted between May 20

Indexed as

Health PersonnelHospitalsAntibodies, NeutralizingAntibodies, ViralCase-Control StudiesCOVID-19HumansInfection ControlOdds RatioRisk FactorsSARS-CoV-2Saudi ArabiaSeroepidemiologic StudiesAntibodies, NeutralizingAntibodies, ViralCOVID-19healthcare workersSARS-CoV-2serologyseroprevalence

Identifiers

PMID33296851
PMCPMC7677039
OpenAlexW3108336065

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.